Management Parameters for Hemiplegic Migraine
Hemiplegic migraine requires specialized management that differs from standard migraine treatment, with careful consideration of medication contraindications and a focus on both acute and preventive therapies to reduce attack frequency and severity.
Diagnosis Parameters
Clinical Criteria for Hemiplegic Migraine
- Must meet ICHD-3 criteria for migraine with aura, plus:
- At least two attacks fulfilling criteria
- Motor weakness (hemiplegia) as an aura symptom
- At least one additional fully reversible aura symptom:
- Visual
- Sensory
- Speech/language
- Brainstem symptoms
- Retinal symptoms 1
Key Diagnostic Features
- Motor weakness is typically unilateral
- Aura symptoms spread gradually over ≥5 minutes
- Each aura symptom lasts 5-60 minutes (motor symptoms may last <72 hours)
- Aura is accompanied by or followed by headache within 60 minutes 1, 2
Classification
- Familial Hemiplegic Migraine (FHM): At least one first-degree relative has identical attacks
- Sporadic Hemiplegic Migraine (SHM): No family history of identical attacks 3
Differential Diagnosis Evaluation
- Neuroimaging (MRI preferred) to rule out:
- Stroke/TIA
- Arterial dissection
- CADASIL
- MELAS
- Moyamoya disease 1
- Consider EEG and CSF analysis to exclude other causes of focal neurological symptoms
- Genetic testing for CACNA1A, ATP1A2, and SCN1A mutations (particularly with additional symptoms like chronic ataxia or epilepsy) 3, 2
CAUTION: Conventional cerebral angiography is contraindicated in hemiplegic migraine as it may trigger attacks 3
Acute Treatment Parameters
First-Line Options
- Acetaminophen and NSAIDs (e.g., aspirin, ibuprofen, naproxen sodium) 1, 3
- Antiemetics for accompanying nausea/vomiting:
- Metoclopramide (10mg oral/IV)
- Prochlorperazine (25mg oral/suppository) 1
Second-Line Options
- Non-oral routes when nausea/vomiting is prominent:
- Intranasal or injectable formulations
- Antiemetics as adjunctive therapy 1
IMPORTANT CONTRAINDICATION: Triptans and ergotamine derivatives are generally contraindicated in hemiplegic migraine due to theoretical risk of vasoconstriction 1, 4
Rescue Therapy
- For severe, prolonged attacks:
Preventive Treatment Parameters
Indications for Preventive Therapy
- Two or more hemiplegic migraine attacks per month
- Attacks producing disability for three or more days per month
- Use of rescue medication more than twice a week
- Failure of acute treatments or contraindications for such treatments 1
First-Line Preventive Options
Calcium channel blockers:
Anticonvulsants:
- Sodium valproate
- Lamotrigine (particularly effective for aura symptoms)
- Acetazolamide (especially in familial cases) 3
Alternative Preventive Options
- Topiramate
- Candesartan
- Pizotifen 3
Emerging Therapies
- Anti-CGRP monoclonal antibodies (galcanezumab) have shown promise in reducing both headache severity and days with weakness in some hemiplegic migraine patients 6
Medications to Use with Caution
- Beta-blockers (e.g., propranolol) - controversial in hemiplegic migraine due to theoretical risk of worsening intracranial vasoconstriction, though evidence of adverse effects is insufficient to absolutely contraindicate 1, 3
Special Considerations
Hormonal Factors
- Oral contraceptives may exacerbate migraine and alter coagulation
- Consider alternative birth control methods for women with hemiplegic migraine 1
Genetic Implications
- Three genes identified (CACNA1A, ATP1A2, SCN1A) affecting ion channels
- Patients with familial hemiplegic migraine mutations may develop persistent neurological deficits and potentially higher stroke risk 1, 3
Monitoring Parameters
- Track attack frequency, severity, duration
- Monitor degree of disability from attacks
- Assess response to treatments
- Document adverse effects from medications
- Identify and track potential triggers 1
Key Pitfall: Failure to distinguish hemiplegic migraine from stroke can lead to inappropriate treatment. Always complete thorough evaluation to rule out other causes of focal neurological deficits before confirming diagnosis.